| Jeffrey M Mahoney, MD | |
|
1120 N 103rd Plz, Suite 100, Omaha, NE 68114-1114 | |
| (402) 391-5055 | |
| (402) 391-5053 |
| Full Name | Jeffrey M Mahoney |
|---|---|
| Gender | Male |
| Speciality | Cardiac Electrophysiology |
| Experience | 28 Years |
| Location | 1120 N 103rd Plz, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245291236 | NPI | - | NPPES |
| 1245291236 | Medicaid | IA | |
| 100264481-00 | Medicaid | NE |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Methodist Fremont Health | Fremont, NE | Hospital |
| Methodist Jennie Edmundson | Council bluffs, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
| Nebraska Methodist Hospital | 6901707447 | 118 |
News Archive
Routine visits to an Optometrist may soon provide us with diagnosis of vision complications and screening for cardiovascular disease.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.
If health care costs continue to grow at the same rate as the last 40 years, income tax rates will need to increase substantially by 2050 if they are the only mechanism used to pay for the additional costs, according to a Congressional Budget Office report released on Monday, CQ HealthBeat reports.
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
› Verified 3 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
Routine visits to an Optometrist may soon provide us with diagnosis of vision complications and screening for cardiovascular disease.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.
If health care costs continue to grow at the same rate as the last 40 years, income tax rates will need to increase substantially by 2050 if they are the only mechanism used to pay for the additional costs, according to a Congressional Budget Office report released on Monday, CQ HealthBeat reports.
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
› Verified 3 days ago
| Entity Name | Nebraska Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628372 PECOS PAC ID: 6901707447 Enrollment ID: O20040116000781 |
News Archive
Routine visits to an Optometrist may soon provide us with diagnosis of vision complications and screening for cardiovascular disease.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.
If health care costs continue to grow at the same rate as the last 40 years, income tax rates will need to increase substantially by 2050 if they are the only mechanism used to pay for the additional costs, according to a Congressional Budget Office report released on Monday, CQ HealthBeat reports.
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey M Mahoney, MD Po Box 3755, Omaha, NE 68103-0755 Ph: (402) 354-2100 | Jeffrey M Mahoney, MD 1120 N 103rd Plz, Suite 100, Omaha, NE 68114-1114 Ph: (402) 391-5055 |
News Archive
Routine visits to an Optometrist may soon provide us with diagnosis of vision complications and screening for cardiovascular disease.
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, and its partner Newron Pharmaceuticals SpA has announced that the first Phase III trial of investigational agent safinamide as adjunctive therapy to levodopa (study 016) met its primary endpoint by increasing daily "ON" time in mid- to late-stage Parkinson's disease patients with motor fluctuations by 1.3 hours.
If health care costs continue to grow at the same rate as the last 40 years, income tax rates will need to increase substantially by 2050 if they are the only mechanism used to pay for the additional costs, according to a Congressional Budget Office report released on Monday, CQ HealthBeat reports.
New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers.
› Verified 3 days ago
Dr. Marium Ilahi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050 | |
Dr. Vidhya Murukesan, M.B.,B.S Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250 | |
Matthew John Kapalis, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255 | |
Abbie K Ray-deering, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440 | |
Dr. Elizabeth Rini Schnaubelt, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581 | |
Sarah Kesterson, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385 | |
Dr. Lauren C Licitra, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000 |